MinervaX reveals completion of vaccine trial enrolment
The company is seeking to address the worldwide impact of group B streptococcus in older adults
Read More
Tag: MinervaX
MinervaX begins critical GBS vaccine trial
Group B streptococcus vaccine study will involve adult groups with and without underlying conditions
Read More
MinervaX reveals financing to development group B streptococcus vaccine
Plans include phase 3 clinical development of novel GBS vaccine and an efficacy evaluation
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
